Recovery of corneal thickness promoted by glucocorticoid administration after phacoemulsification in eyes affected by Fuchs' dystrophy.
Chikamoto
Nobuhiko
N
Department of Ophthalmology, Yamaguchi University Graduate School of Medicine, Ube, Yamaguchi, Japan. chikamot@po.cc.yamaguchi-u.ac.jp.
Takahashi
Norihisa
N
Department of Ophthalmology, Yamaguchi University Graduate School of Medicine, Ube, Yamaguchi, Japan.
Wakuta
Makiko
M
Department of Ophthalmology, Yamaguchi University Graduate School of Medicine, Ube, Yamaguchi, Japan.
Fujitsu
Youichiro
Y
Department of Ophthalmology, Yamaguchi University Graduate School of Medicine, Ube, Yamaguchi, Japan.
Nishida
Teruo
T
Department of Ophthalmology, Yamaguchi University Graduate School of Medicine, Ube, Yamaguchi, Japan.
D000368:Aged; D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D001623:Betamethasone / Q000008:administration & dosage; D002452:Cell Count; D003318:Corneal Opacity / Q000503:physiopathology; D003907:Dexamethasone / Q000008:administration & dosage; D003982:Dibekacin / Q000008:administration & dosage; D004728:Endothelium, Corneal / Q000187:drug effects / Q000503:physiopathology*; D005642:Fuchs' Endothelial Dystrophy / Q000150:complications* / Q000503:physiopathology; D005938:Glucocorticoids / Q000008:administration & dosage*; D006801:Humans; D019654:Lens Implantation, Intraocular; D008297:Male; D018613:Microscopy, Confocal; D018918:Phacoemulsification; D011183:Postoperative Complications; D014792:Visual Acuity
D000900:Anti-Bacterial Agents; D005938:Glucocorticoids; D003982:Dibekacin; D003907:Dexamethasone; D001623:Betamethasone
Jpn J Ophthalmol. 2000 Sep-Oct;44(5):520-3
11033131
Ocul Immunol Inflamm. 2006 Aug;14(4):215-23
16911983
Invest Ophthalmol Vis Sci. 1988 Mar;29(3):357-61
3257749
Acta Ophthalmol (Copenh). 1993 Feb;71(1):89-94
8475720
Ophthalmology. 2005 Mar;112(3):441-6
15745771